Muvadenant

DB21684ExperimentalSmall molecule

Muvadenant is a small molecule drug. The usage of the INN stem '-adenant' in the name indicates that Muvadenant is a adenosin receptor antagonist. Muvadenant has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Adenosine receptor A2b and Adenosine receptor A2a
Curator reviewed
Formula / weight: C₂₁H₂₆N₄O₄S · 430.52 g/mol (avg)

Resolves to

Compound

UNII6LSF69F6A8CAS2459881-03-7ChEMBLCHEMBL5569567ChEBI759853PubChem154659422

Structure

InChIKeyCSSAKLQGJYJMNW-NRFANRHFSA-NSMILESCOC1=C2N=C(NC(=O)N3CC[C@]4(C3)CCCOC4)SC2=C(C=N1)C1=CCOCC1

Targets

P29275ADORA2BP29274ADORA2A

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Muvadenant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account